Enanta Pharmaceuticals has an EPS of $-6.38. In 2022, the company made an earnings per share (EPS) of $-5.91. Earnings Per Share (EPS) is a financial metric that measures a company's profit allocated to each outstanding share of its common stock. It is calculated by dividing the company's net earnings by the number of outstanding shares.
Year | EPS | Change |
---|---|---|
2023 | -$6.38 | 7.95% |
2022 | -$5.91 | 50.77% |
2021 | -$3.92 | 116.57% |
2020 | -$1.81 | - |